Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

931
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
931
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

1.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

642
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
642
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

865
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
865

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cardiovascular outcomes of empagliflozin-GLP-1RA combination therapy in type 2 diabetes: EMPRISE study.

Cardiovascular diabetology·2026
Same author

Prevalence and frequency of haematological testing in patients initiating clozapine in the USA.

BMJ mental health·2026
Same author

PregMedNet: Multifaceted maternal medication impacts on neonatal complications.

Nature communications·2026
Same author

Development of Longitudinal, Linked Maternal-Infant Cohorts using the Epic Cosmos Electronic Health Record Dataset.

medRxiv : the preprint server for health sciences·2026
Same author

Continuing Glucagon-Like Peptide-1 Receptor Agonists Into the First Trimester of Pregnancy and Pregnancy Outcomes : A Target Trial Emulation Study Using Claims Information.

Annals of internal medicine·2026
Same author

Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.

Diabetes, obesity & metabolism·2026

相关实验视频

Updated: Jan 17, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.2K

在接受氧化启动选择性色素再吸收抑制剂的患者中,阿片类药物过量服用的比较风险.

Katsiaryna Bykov1, C Andrew Basham1, Nazleen F Khan1

  • 1From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Epidemiology (Cambridge, Mass.)
|September 15, 2025
PubMed
概括

选择性血清素再吸收抑制剂 (SSRI) 与氧化联合处方显示,阿片类药物过量发生率较低. 与其他SSRI相比,塞特拉林在添加到氧化时与略低的过量剂量率有关.

关键词:
群组研究是指群组研究.药物相互作用 药物相互作用药物安全 药物安全过量服用阿片类药物这是一种阿片类药物.氧化的氧化是最重要的.药理流行病学 药理流行病学选择性血清素再吸收抑制剂 选择性血清素再吸收抑制剂

更多相关视频

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.6K
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
09:29

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

Published on: January 9, 2015

15.8K

相关实验视频

Last Updated: Jan 17, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.2K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.6K
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
09:29

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

Published on: January 9, 2015

15.8K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 临床药房 临床药房
  • 流行病学 流行病学

背景情况:

  • 选择性血清素再吸收抑制剂 (SSRI) 经常与氧化一起处方.
  • 简单的SSRI可能会强化阿片类药物诱导的呼吸抑制.
  • 对阿片类药物过量与不同SSRI添加到氧化的比较风险尚未得到充分确立.

研究的目的:

  • 为了比较在服用氧化时启动不同的SSRI的患者中阿片类药物过量剂的风险.
  • 评估特定的SSRI (塞特拉林,西塔洛普拉姆,埃斯基塔洛普拉姆,弗卢克塞丁,帕罗克塞丁) 对阿片类药物过量风险的比较影响.

主要方法:

  • 一项使用美国商业和公共医疗保险索赔数据 (2004-2020) 的队列研究.
  • 包括在氧化时开始服用SSRI的成年人,并对阿片类药物过量事件进行365天的跟踪.
  • 倾向性得分匹配和加权的考克斯比例危险模型被用于估计危险比率.

主要成果:

  • 这项研究包括了753,263名与氧化一起启动SSRI的个人.
  • 在SSRI中,阿片类药物过量发生率在1000人/年内从10.8到15.2不等.
  • 与塞特拉林相比,其他SSRI显示过量服用的危险比率略高 (例如,citalopram HR 1.24,fluoxetine HR 1.26).

结论:

  • 在将SSRI添加到氧化的患者中,阿片类药物过量发生率较低.
  • 与其他研究的SSRI相比,塞特拉林与阿片类药物过量剂量率的统计学上相似,但数量较低.
  • 研究结果表明,在与氧化联合处方时,SSRI之间存在潜在的过量风险差异.